Reimagining Indian MedTech: How Truevis is redefining imaging, innovation and self-reliance

Milind Deshpande, Joint Managing Director, Truevis Technologies, outlines how India's MedTech ecosystem is undergoing a structural shift driven by rising diagnostic demand, healthcare self-reliance and the expansion of advanced care beyond metros

- 

India's healthcare system is at a pivotal juncture. Rising diagnostic demand, expanding insurance coverage and national priorities around healthcare self-reliance are reshaping how advanced medical technologies are deployed across the country. As diagnostic and therapeutic capabilities move beyond metropolitan centres into Tier-2 and Tier-3 cities, the need for accessible, reliable and cost-effective medical technology has never been greater. In this evolving landscape, Truevis Technologies—with manufacturing at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam—is emerging as a next-generation MedTech company focused on building advanced imaging and oncology solutions tailored for India.

Democratising access to advanced imaging

Advanced imaging modalities such as PET-CT have traditionally been limited to large tertiary hospitals due to high capital costs, import dependence and complex service requirements. This concentration has restricted access for patients in regional markets and slowed the expansion of comprehensive oncology diagnostics. Truevis is addressing this gap through a localised manufacturing and lifecycle-cost optimisation model. By designing, assembling and servicing systems within India, the company is enabling hospitals beyond major metros to adopt technologies once considered out of reach, supporting national initiatives such as Ayushman Bharat and advancing healthcare equity.

Engineering depth and global collaboration